CTSH vs STRO · P/E 12, rev $19.74B vs rev $62.0M
Cognizant Technology Solutions Corp Class A (CTSH) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CTSH revenue for 2024-12-31 was $19.74B. Net income was $2.24B. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CTSH and STRO stock pages for the full models.
Not investment advice.